Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;152(5):442-443.
doi: 10.4103/ijmr.IJMR_2709_19.

Nab-paclitaxel - Third-line chemotherapy in advanced gallbladder cancer

Amol Patel  1 , Bhawna Sirohi  2
Affiliations
Comment

Nab-paclitaxel - Third-line chemotherapy in advanced gallbladder cancer

Amol Patel et al. Indian J Med Res. 2020 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None

Comment on

References

    1. National Cancer Registry Programme. Consolidated Report of Population Based Cancer Registries: 2012-14. [accessed on December 19, 2019]. Available from: http://ncdirindia.org/NCRP/ALL_NCRP_REPORTS/PBCR_REPORT_2012_2014/index.htm .
    1. Sirohi B, Singh A, Jagannath P, Shrikhande SV. Chemotherapy and targeted therapy for gall bladder cancer. Indian J Surg Oncol. 2014;5:134–41. - PMC - PubMed
    1. Shukla HS, Sirohi B, Behari A, Sharma A, Majumdar J, Ganguly M, et al. Indian Council of Medical Research Consensus Document for the management of gall bladder cancer. Indian J Med Paediatr Oncol. 2015;36:79–84. - PMC - PubMed
    1. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273–81. - PubMed
    1. Talwar V, Raina S, Goel V, Dash P, Doval DC. Nab-paclitaxel - An effective third line chemotherapy in patients with advanced, unresectable gallbladder cancer. Indian J Med Res. 2020;152:475–81. - PMC - PubMed